Zhi Yang Ng

Dr. Zhi Yang Ng

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Annals of Surgery
Verified
Journal Article
Closed access
PDF file
CCCurtis L. Cetrulo
Curtis L. Cetrulo
KLKai Li
Kai Li
HSHarry M. Salinas
Harry M. Salinas
MTMatthew D. Treiser
Matthew D. Treiser
ISIlse Schol
Ilse Schol
DKDicken S. C. Ko
Dicken S. C. Ko
Objective: We describe the first successful penis transplant in the United States in a patient with a history of subtotal penectomy for penile cancer. Background: Penis transplantation represents a new paradigm in restoring anatomic appearance, urine conduit, and sexual function after genitourinary tissue loss. To date, only 2 penis transplants have been performed worldwide. Methods: After institutional review board approval, extensive medical, surgical, and radiological evaluations of the patient were performed. His candidacy was reviewed by a multidisciplinary team of surgeons, physicians, psychiatrists, social workers, and nurse coordinators. After appropriate donor identification and recipient induction with antithymocyte globulin, allograft procurement and recipient preparation took place concurrently. Anastomoses of the urethra, corpora, cavernosal and dorsal arteries, dorsal vein, and dorsal nerves were performed, and also inclusion of a donor skin pedicle as the composite allograft. Maintenance immunosuppression consisted of mycophenolate mofetil, tacrolimus, and methylprednisolone. Results: Intraoperative, the allograft had excellent capillary refill and strong Doppler signals after revascularization. Operative reinterventions on postoperative days (PODs) 2 and 13 were required for hematoma evacuation and skin eschar debridement. At 3 weeks, no anastomotic leaks were detected on urethrogram, and the catheter was removed. Steroid resistant-rejection developed on POD 28 (Banff I), progressed by POD 32 (Banff III), and required a repeat course of methylprednisolone and antithymocyte globulin. At 7 months, the patient has recovered partial sensation of the penile shaft and has spontaneous penile tumescence. Our patient reports increased overall health satisfaction, dramatic improvement of self-image, and optimism for the future. Conclusions: We have shown that it is feasible to perform penile transplantation with excellent results. Furthermore, this experience demonstrates that penile transplantation can be successfully performed with conventional immunosuppression. We propose that our successful penile transplantation pilot experience represents a proof of concept for an evolution in reconstructive transplantation.

1 January 2014 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
ZNZhi Yang Ng
Zhi Yang Ng
INIrfan Nawaz
Irfan Nawaz
Polyetheretherketone (PEEK) is a synthetic material that was used initially in spine and hip surgery. It has the properties of being biocompatible, resistant to thermal and ionizing radiation, and resembles cortical bone biomechanically. These favorable characteristics have led to the increasing use of PEEK implants for calvarial defects which remain a significant reconstructive challenge. This study is a retrospective review of patients who underwent PEEK cranioplasty by a single surgeon. PEEK implants were fashioned from high-resolution CT scans of each patient and sterilized preoperatively before cranioplasty was performed using standard techniques. The mean follow-up period was 7 months (range 1-22). Twelve consecutive patients (75% males; mean age = 43, range 16-67) underwent PEEK cranioplasty between January 2011 and December 2012 after a mean time interval of 10 months (range 3-40) following initial craniectomy. The mean defect size was 11 × 8 cm (range 7 × 6 to 14 × 8 cm) and no additional contouring of PEEK implants was necessary intraoperatively. The scalp was closed primarily in all patients, and no complications of implant breakdown, wound infection, or cerebrospinal fluid leak were appreciated during follow-up. Computer-designed, patient-specific PEEK implants for cranioplasties are a viable alternative when autologous bone grafts are unavailable or unsuitable. Such prefabrication reduces operative times through minimal to no intraoperative adjustments. Although initial results are promising, longer-term follow-up and further comparative studies including randomized control trials to evaluate outcomes between different alloplastic materials for cranioplasty are necessary.

1 December 2010 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
ZNZhi Yang Ng
Zhi Yang Ng
QFQuentin A. Fogg
Quentin A. Fogg
TSTaimur Shoaib
Taimur Shoaib

4 March 2019 in Transplant International
Verified
Journal Article
Closed access
PDF file
ZNZhi Yang Ng
Zhi Yang Ng
ALAlexandre G Lellouch
Alexandre G Lellouch
IRIvy A. Rosales
Ivy A. Rosales
LGLuke Geoghegan
Luke Geoghegan
AGAmon‐Ra Gama
Amon‐Ra Gama
CJCurtis L Cetrulo Jr
Curtis L Cetrulo Jr
Mechanisms of chronic rejection of vascularized composite allografts (VCA) remain poorly understood and likely present along a spectrum of highly varied clinicopathological findings. Across both animal and human VCA however, graft vasculopathy (GV) has been the most consistent pathological finding resulting clinically in irreversible allograft dysfunction and eventual loss. A literature review of all reported clinical VCA cases with documented GV up to December 2018 was thus performed to elucidate the possible mechanisms involved. Relevant data extracted include C4d deposition, donor‐specific antibody (DSA) formation, extent of human leukocyte antigen (HLA) mismatch, pretransplant panel reactive antibody levels, induction and maintenance immunosuppression used, the number of preceding acute rejection episodes, and time to histological confirmation of GV. Approximately 6% (13 of 205) of all VCA patients reported to date developed GV at a mean of 6 years post‐transplantation. 46% of these patients have either lost or had their VCAs removed. Neither C4d nor DSA alone was predictive of GV development; however, when both are present, VCA loss appears inevitable due to progressive GV. Of utmost concern, GV in VCA does not appear to be abrogated by currently available immunosuppressive treatment and is essentially irreversible by the time of diagnosis with allograft loss a likely eventuality.

1 November 2014 in Hand Clinics
Verified
Journal Article
Closed access
HCHarvey Chim
Harvey Chim
ZNZhi Yang Ng
Zhi Yang Ng
BCBrian T. Carlsen
Brian T. Carlsen
AMAnita T. Mohan
Anita T. Mohan
MSMichel Saint-Cyr
Michel Saint-Cyr

4 February 2015 in Seminars in Plastic Surgery
Verified
Journal Article
Closed access
PDF file
ZNZhi Yang Ng
Zhi Yang Ng
MAMorad Askari
Morad Askari
HCHarvey Chim
Harvey Chim
Patients with complex upper extremity injuries represent a unique subset of the trauma population. In addition to extensive soft tissue defects affecting the skin, bone, muscles and tendons, or the neurovasculature in various combinations, there is usually concomitant involvement of other body areas and organ systems with the potential for systemic compromise due to the underlying mechanism of injury and resultant sequelae. In turn, this has a direct impact on the definitive reconstructive plan. Accurate assessment and expedient treatment is thus necessary to achieve optimal surgical outcomes with the primary goal of limb salvage and functional restoration. Nonetheless, the characteristics of these injuries places such patients at an increased risk of complications ranging from limb ischemia, recalcitrant infections, failure of bony union, intractable pain, and most devastatingly, limb amputation. In this article, the authors present an algorithmic approach toward complex injuries of the upper extremity with due consideration for the various reconstructive modalities and timing of definitive wound closure for the best possible clinical outcomes.